These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

474 related items for PubMed ID: 24220667

  • 1. Multicenter voxel-based morphometry mega-analysis of structural brain scans in obsessive-compulsive disorder.
    de Wit SJ, Alonso P, Schweren L, Mataix-Cols D, Lochner C, Menchón JM, Stein DJ, Fouche JP, Soriano-Mas C, Sato JR, Hoexter MQ, Denys D, Nakamae T, Nishida S, Kwon JS, Jang JH, Busatto GF, Cardoner N, Cath DC, Fukui K, Jung WH, Kim SN, Miguel EC, Narumoto J, Phillips ML, Pujol J, Remijnse PL, Sakai Y, Shin NY, Yamada K, Veltman DJ, van den Heuvel OA.
    Am J Psychiatry; 2014 Mar; 171(3):340-9. PubMed ID: 24220667
    [Abstract] [Full Text] [Related]

  • 2. Widespread decreased grey and white matter in paediatric obsessive-compulsive disorder (OCD): a voxel-based morphometric MRI study.
    Chen J, Silk T, Seal M, Dally K, Vance A.
    Psychiatry Res; 2013 Jul 30; 213(1):11-7. PubMed ID: 23701704
    [Abstract] [Full Text] [Related]

  • 3. White matter structural alterations in pediatric obsessive-compulsive disorder: relation to symptom dimensions.
    Lázaro L, Ortiz AG, Calvo A, Ortiz AE, Moreno E, Morer A, Calvo R, Bargallo N.
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct 03; 54():249-58. PubMed ID: 24977330
    [Abstract] [Full Text] [Related]

  • 4. Increased orbital frontal gray matter volume after cognitive behavioural therapy in paediatric obsessive compulsive disorder.
    Huyser C, van den Heuvel OA, Wolters LH, de Haan E, Boer F, Veltman DJ.
    World J Biol Psychiatry; 2013 May 03; 14(4):319-31. PubMed ID: 22746998
    [Abstract] [Full Text] [Related]

  • 5. Gray matter structural alterations in psychotropic drug-naive pediatric obsessive-compulsive disorder: an optimized voxel-based morphometry study.
    Szeszko PR, Christian C, Macmaster F, Lencz T, Mirza Y, Taormina SP, Easter P, Rose M, Michalopoulou GA, Rosenberg DR.
    Am J Psychiatry; 2008 Oct 03; 165(10):1299-307. PubMed ID: 18413702
    [Abstract] [Full Text] [Related]

  • 6. Regional gray and white matter volume abnormalities in obsessive-compulsive disorder: a voxel-based morphometry study.
    Togao O, Yoshiura T, Nakao T, Nabeyama M, Sanematsu H, Nakagawa A, Noguchi T, Hiwatashi A, Yamashita K, Nagao E, Kanba S, Honda H.
    Psychiatry Res; 2010 Oct 30; 184(1):29-37. PubMed ID: 20833001
    [Abstract] [Full Text] [Related]

  • 7. Morphometric brain characterization of refractory obsessive-compulsive disorder: diffeomorphic anatomic registration using exponentiated Lie algebra.
    Tang W, Li B, Huang X, Jiang X, Li F, Wang L, Chen T, Wang J, Gong Q, Yang Y.
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct 01; 46():126-31. PubMed ID: 23876787
    [Abstract] [Full Text] [Related]

  • 8. Structural brain abnormalities correlate with clinical features in patients with drug-naïve OCD: A DARTEL-enhanced voxel-based morphometry study.
    Tang W, Huang X, Li B, Jiang X, Li F, Xu J, Yang Y, Gong Q.
    Behav Brain Res; 2015 Nov 01; 294():72-80. PubMed ID: 26241173
    [Abstract] [Full Text] [Related]

  • 9. Regional gray matter abnormalities in obsessive-compulsive disorder: a voxel-based morphometry study.
    Valente AA, Miguel EC, Castro CC, Amaro E, Duran FL, Buchpiguel CA, Chitnis X, McGuire PK, Busatto GF.
    Biol Psychiatry; 2005 Sep 15; 58(6):479-87. PubMed ID: 15978549
    [Abstract] [Full Text] [Related]

  • 10. Biological heterogeneity of obsessive-compulsive disorder: A voxel-based morphometric study based on dimensional assessment.
    Okada K, Nakao T, Sanematsu H, Murayama K, Honda S, Tomita M, Togao O, Yoshiura T, Kanba S.
    Psychiatry Clin Neurosci; 2015 Jul 15; 69(7):411-21. PubMed ID: 25556718
    [Abstract] [Full Text] [Related]

  • 11. Cerebral white matter volume changes in patients with obsessive-compulsive disorder: Voxel-based morphometry.
    Park SE, Jeong GW.
    Psychiatry Clin Neurosci; 2015 Nov 15; 69(11):717-23. PubMed ID: 25966931
    [Abstract] [Full Text] [Related]

  • 12. Regional gray matter changes in obsessive-compulsive disorder: relationship to clinical characteristics.
    Exner C, Zetsche U, Martin V, Rief W, Jansen A.
    Psychiatry Res; 2012 Apr 30; 202(1):74-6. PubMed ID: 22595507
    [Abstract] [Full Text] [Related]

  • 13. Reduced thickness of anterior cingulate cortex in obsessive-compulsive disorder.
    Kühn S, Kaufmann C, Simon D, Endrass T, Gallinat J, Kathmann N.
    Cortex; 2013 Sep 30; 49(8):2178-85. PubMed ID: 23067727
    [Abstract] [Full Text] [Related]

  • 14. Gray matter differences between pediatric obsessive-compulsive disorder patients and high-risk siblings: a preliminary voxel-based morphometry study.
    Gilbert AR, Keshavan MS, Diwadkar V, Nutche J, Macmaster F, Easter PC, Buhagiar CJ, Rosenberg DR.
    Neurosci Lett; 2008 Apr 11; 435(1):45-50. PubMed ID: 18314272
    [Abstract] [Full Text] [Related]

  • 15. The major symptom dimensions of obsessive-compulsive disorder are mediated by partially distinct neural systems.
    van den Heuvel OA, Remijnse PL, Mataix-Cols D, Vrenken H, Groenewegen HJ, Uylings HB, van Balkom AJ, Veltman DJ.
    Brain; 2009 Apr 11; 132(Pt 4):853-68. PubMed ID: 18952675
    [Abstract] [Full Text] [Related]

  • 16. Changes in gray matter volume and white matter microstructure in adolescents with obsessive-compulsive disorder.
    Zarei M, Mataix-Cols D, Heyman I, Hough M, Doherty J, Burge L, Winmill L, Nijhawan S, Matthews PM, James A.
    Biol Psychiatry; 2011 Dec 01; 70(11):1083-90. PubMed ID: 21903200
    [Abstract] [Full Text] [Related]

  • 17. White matter abnormalities in obsessive-compulsive disorder: a diffusion tensor imaging study.
    Szeszko PR, Ardekani BA, Ashtari M, Malhotra AK, Robinson DG, Bilder RM, Lim KO.
    Arch Gen Psychiatry; 2005 Jul 01; 62(7):782-90. PubMed ID: 15997020
    [Abstract] [Full Text] [Related]

  • 18. A voxel-based morphometric MRI study of stabilized obsessive-compulsive adolescent patients.
    Lázaro L, Castro-Fornieles J, Cullell C, Andrés S, Falcón C, Calvo R, Bargalló N.
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Dec 01; 35(8):1863-9. PubMed ID: 21840363
    [Abstract] [Full Text] [Related]

  • 19. Differential prefrontal gray matter correlates of treatment response to fluoxetine or cognitive-behavioral therapy in obsessive-compulsive disorder.
    Hoexter MQ, Dougherty DD, Shavitt RG, D'Alcante CC, Duran FL, Lopes AC, Diniz JB, Batistuzzo MC, Evans KC, Bressan RA, Busatto GF, Miguel EC.
    Eur Neuropsychopharmacol; 2013 Jul 01; 23(7):569-80. PubMed ID: 22841131
    [Abstract] [Full Text] [Related]

  • 20. Brain structural abnormalities in psychotropic drug-naive pediatric patients with obsessive-compulsive disorder.
    Szeszko PR, MacMillan S, McMeniman M, Chen S, Baribault K, Lim KO, Ivey J, Rose M, Banerjee SP, Bhandari R, Moore GJ, Rosenberg DR.
    Am J Psychiatry; 2004 Jun 01; 161(6):1049-56. PubMed ID: 15169693
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.